精准影像医学专题 |
|
|
|
|
PET-CT诊断ⅠA2~ⅡA期宫颈癌原发灶和盆腔淋巴结转移的价值 |
傅立平, 程爱萍, 孙美玲, 王晓刚, 付涧兰 |
浙江省人民医院核医学科, 浙江 杭州 310014 |
|
Value of 18F-FDG PET-CT in detection of primary lesion and pelvic lymph node metastasis in FIGO stages ⅠA2-ⅡA cervical cancer |
FU Liping, CHENG Aiping, SUN Meiling, WANG Xiaogang, FU Jianlan |
Department of Nuclear Medicine, Zhejiang Provincial People's Hospital, Hangzhou 310014, China |
[1] |
CHONG G O, JEONG S Y, PARK S H, et al. Comparison of the prognostic value of F-18 pet metabolic parameters of primary tumors and regional lymph nodes in patients with locally advanced cervical cancer who are treated with concurrent chemoradiotherapy[J/OL]. PLoS One,2015,10(9):e0137743.
|
[2] |
HONG J H, MIN K J, LEE J K, et al. Prognostic value of the sum of metabolic tumor volume of primary tumor and lymph nodes using 18F-FDG PET/CT in patients with cervical cancer[J]. Medicine (Baltimore),2016,95(9):e2992.
|
[3] |
LAI C H, LIN G, YEN T C, et al. Molecular imaging in the management of gynecologic malignancies[J]. Gynecol Oncol,2014,135(1):156-162.
|
[4] |
陈峰,林天增,郁春景,等.18F-FDG PET/CT显像在治疗后宫颈癌评估中的价值[J].中华核医学与分子影像杂志,2015,35(3):164-167. CHEN Feng, LIN Tianzeng,YU Chunjing, et al. Value of 18F-FDG PET/CT in the post-treatment evaluation of cervical cancer[J]. Chinese Journal of Nuclear Medicine and Molecular Imaging,2015,35(3):164-167. (in Chinese)
|
[5] |
王全师.18F-FDG PET/CT在宫颈癌中的临床价值[J].中华核医学与分子影像杂志,2015,35(3):161-163. WANG Quanshi. Clinical value of 18F-FDG PET/CT in cervical cancer[J]. Chinese Journal of Nuclear Medicine and Molecular Imaging,2015,35(3):161-163. (in Chinese)
|
[6] |
王伟,尚春亮,黄佳明,等.腹腔镜与开腹行子宫广泛性切除术治疗Ⅰa2~Ⅱa2期子宫颈癌的可行性及肿瘤结局的配对队列研究[J].中华妇产科杂志,2015,50(12):894-901. WANG Wei, SHANG Chunliang, HUANG Jiaming, et al. Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage Ⅰa2-Ⅱa2 cervical cancer:a matched cohort study[J]. Chinese Journal of Obstetrics and Gynecology,2015,50(12):894-901. (in Chinese)
|
[7] |
OBRZUT B, SEMCZUK A, NARÓG M, et al. Prognostic parameters for patients with cervical cancer FIGO stages ⅠA2-ⅡB:a long-term follow-up[J]. Oncology,2017,93(2):106-114.
|
[8] |
ESCANDE A, GOUY S, MAZERON R, et al. Outcome of early stage cervical cancer patients treated according to a radiosurgical approach:clinical results and prognostic factors[J]. Gynecol Oncol,2017,144(3):541-546.
|
[9] |
LEE Y J, KIM D Y, LEE S W, et al. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection[J]. Gynecol Oncol,2017,144(3):536-540.
|
[10] |
TOGAMI S, KAMIO M, YANAZUME S, et al. Can pelvic lymphadenectomy be omitted in stage IA2 to ⅡB uterine cervical cancer?[J]. Int J Gynecol Cancer,2014,24(6):1072-1076.
|
[11] |
龚静,张军.《2016年NCCN宫颈癌临床实践指南》解读[J].中国全科医学,2016,19(27):3261-3264. GONG Jing, ZHANG Jun. Interpretation of NCCN Clinical Practice Guidelines in Oncology:Cervical Cancer (Version 1. 2016)[J]. Chinese General Practice,2016,19(27):3261-3264. (in Chinese)
|
[12] |
VURAL G U, AKKAS B E, DEMIREL B B. Standardized uptake value and metabolic tumor volume measured by 18F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma[J]. Rev Esp Med Nucl Imagen Mol,2014,33(5):268-273.
|
[13] |
LV K, GUO H M, LU Y J, et al. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer:comparison with MRI findings[J]. Nucl Med Commun,2014,35(12):1204-1211.
|
[14] |
TONG S Y, LEE J M, KI K D, et al. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase Ⅱ in cervical cancer[J]. Int J Gynecol Cancer,2012,22(4):654-658.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|